Company Filing History:
Years Active: 2015
Title: Hsiao-Chun Wang: Innovator in Protein Kinase Inhibitors
Introduction
Hsiao-Chun Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutic compounds.
Latest Patents
Wang holds a patent for "Indolin-2-one derivatives as protein kinase inhibitors." This patent describes a new class of indoline-2-one derivatives that serve as protein kinase inhibitors. These compounds are particularly useful in treating hyperproliferative diseases, including cancer. The invention includes a compound of Formula A or a pharmaceutically acceptable salt thereof.
Career Highlights
Hsiao-Chun Wang is associated with Annji Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work focuses on creating innovative solutions for complex medical challenges.
Collaborations
Wang has collaborated with notable colleagues, including Ji-Wang Chern and Ajit Dhananjay Jagtap, to further enhance the impact of his research.
Conclusion
Hsiao-Chun Wang's contributions to the field of protein kinase inhibitors highlight his role as a key innovator in the pharmaceutical industry. His work has the potential to significantly impact the treatment of cancer and other hyperproliferative diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.